Thermo Fisher Scientific: Q2 Earnings Insights


Shares of Thermo Fisher Scientific TMO remained unaffected after the company reported Q2 results.

Quarterly Results

Earnings per share rose 43.96% over the past year to $5.60, which beat the estimate of $5.49.

Revenue of $9,273,000,000 higher by 34.06% from the same period last year, which beat the estimate of $8,770,000,000.


The upcoming fiscal year's EPS expected to be between $22.07 and $22.07.

The upcoming fiscal year's revenue expected to be between $35,900,000,000 and $35,900,000,000.

Conference Call Details

Date: Jul 28, 2021

Time: 08:30 AM

ET Webcast URL:


52-week high: $534.50

52-week low: $401.06

Price action over last quarter: Up 12.77%

Company Profile

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (17%); life science solutions (38%); and lab products and services (38%).

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!